To screen or not to screen older women for breast cancer: A conundrum

Future Oncology

Volumn 9, Issue 6, 2013, Pages 763-766

  Braithwaite, Dejana ^a   Mandelblatt, Jeanne S ^b   Kerlikowske, Karla ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

false positive results; life expectancy based screening; overdiagnosis; risk based screening; screening frequency; screening mammography

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84878492454     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.64     Document Type: Review

References (22)

1. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21), 2750-2756 (2001).
2. Mandelblatt JS, Schechter CB, Yabroff KR et al. Toward optimal screening strategies for older women. Costs, benefts, and harms of breast cancer screening by age, biology, and health status. J. Gen. Intern. Med. 20(6), 487-496 (2005).
3. Gross CP, Long JB, Ross JS et al. The cost of breast cancer screening in the Medicare population. JAMA 173 (3), 220-226 (2013)
4. US Preventive Services Task Force. Screening for breast cancer: recommendations and Rationale. Ann Intern Med. 151, 716-726 (2009).
5. Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J. Clin. 63(2), 88-105 (2013).
6. Galit W, Green MS, Lital KB. Routine screening mammography in women older than 74 years: a review of the available data. Maturitas 57(2), 109-119 (2007).
7. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 151(10), 727-737 (2009).
8. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359(9310), 909-919 (2002).
9. Mandelblatt JS, Silliman R. Hanging in the balance: making decisions about the benefts and harms of breast cancer screening among the oldest old without a safety net of scientifc evidence. J. Clin. Oncol. 27(4), 487-490 (2009).
10. Berry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gotzsche PC et al. Flawed inferences about screening mammography's beneft based on observational data. J. Clin. Oncol. 27(4), 639-640; author reply 641-642 (2009).
11. Mandelblatt JS, Cronin KA, Bailey S et al. Effects of mammography screening under different screening schedules: model estimates of potential benefts and harms. Ann. Intern. Med. 151(10), 738-747 (2009).
12. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann. Intern. Med. 155(8), 481-492 (2011).
13. Braithwaite D, Zhu W, Hubbard RA et al. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age or comorbidity score affect tumor characteristics or false positive rates? J. Natl Cancer Inst. doi:10.1093/jnci/djs645 (2013) (Epub ahead of print).
14. US Census Bureau. Current Population Reports, P25-1095. Table US-EST90INT-04-Intercensal Estimates of the United States Resident Population by Age Groups and Sex, 1990-2000: Selected Months. US Census Bureau, MD, USA (2002).
15. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefts and cost-effectiveness. Ann. Intern. Med. 155(1), 10-20 (2011).
16. Kerlikowske K, Zhu W, Hubbard RA et al. Outcomes of screening mammography by frequency, breast density and postmenopausal hormone therapy. JAMA Intern. Med. 18, 1-10 (2013).
17. Ernster VL, Ballard-Barbash R, Barlow WE et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J. Natl Cancer Inst. 94(20), 1546-1554 (2002).
18. Randolph WM, Goodwin JS, Mahnken JD, Freeman JL. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann. Intern. Med. 137(10), 783-790 (2002).
19. Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann. Intern. Med. 116 (9), 722-730 (1992).
20. Yasmeen S, Hubbard RA, Romano PS et al. Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol. Biomarkers Prev. 21(9), 1510-1519 (2012).
21. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to beneft after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 346, e8441 (2012).
22. Cruz M, Covinsky K, Widera EW, Stijacic-Cenzer I, Lee SJ. Predicting 10-year mortality for older adults. JAMA 309(9), 874-876 (2013).